Nimbus, Charles River deal

Nimbus and Charles River partnered to discover and develop compounds against undisclosed targets provided by Nimbus to treat immunological and metabolic disorders, as well as cancer. The partners will form a joint-steering committee to advance the compounds through preclinical development. ...